Todd Unger, Chief Experience Officer of AMA, and Dr. Kirsten Bibbins-Domingo, Editor-in-Chief of JAMA and the JAMA Network, recently spoke about the highlights of 2023 and the exciting things to come in 2024 in an AMA Update video and podcast.
Considering 2023: An Ambitious Year
Dr. Bibbins-Domingo emphasized the accomplishments of the 13 notable publications that are part of the JAMA Network. One noteworthy achievement was the first-ever JAMA Summit, which was held in person. 60 professionals from across the world convened at the summit to talk about closing the knowledge gap between clinical practice and evidence development.
Important Research on Weight Loss Treatments and Alzheimer’s
The discussion turned to the significant findings that were released in 2023 and concentrated on GLP-1 inhibitors for weight reduction and therapies connected to Alzheimer’s disease. The continuous development of therapeutic zones across the network was stressed by Dr. Bibbins-Domingo.
Artificial Intelligence’s Ascent in Medicine
Dr. Bibbins-Domingo expressed optimism about the future, pointing out that the network is dedicated to disseminating ground-breaking research and that novel medicines are always growing. It was noted that medical practice and research are being revolutionized by artificial intelligence (AI), which brings with it both potential and problems.
AI and Novel Therapeutics: Accelerated Discoveries
The link between AI and novel treatments was covered in detail in the conversation. While not every novel treatment has a direct connection to artificial intelligence, Dr. Bibbins-Domingo clarified that faster and more extensive data manipulation is leading to more rapid discoveries. Journals are essential for explaining the true consequences of developments and for distinguishing hype from hope.
Objectives for 2024: Communication, Trust, and Speed
In 2024, Dr. Bibbins-Domingo stressed the significance of building on the journals’ established advantages as a reliable source of knowledge and accelerating communication. Recognizing that audiences’ reading habits are changing, JAMA has made the commitment to speedier information distribution evident by moving to an online-first publication model.
JAMA Conferences and the Growth of Multimedia
There was talk of new projects and excitement for additional JAMA Summits. Expanding multimedia material and engaging with writers are important, according to Dr. Bibbins-Domingo. Aiming to satisfy a wide range of audience tastes, short-form articles on several platforms offer both detailed and condensed information.
You Might Be Interested In
- The New Way: Using Google Cloud and Generative AI, HCA Healthcare is Redesigning Patient Care
- Optimal Mental Clarity with 15-Minute Meditative Journaling and AI: Promoting Well-Being in a Fast-Paced World
Animated Crowds: Handling Science and Research
While acknowledging the excitement of audiences drawn to science and research, Dr. Bibbins-Domingo underlined the difficulty of staying current in the ever-evolving area. Delivering information in a way that satisfies the demands of the voracious audience remains the aim.
"Discover the latest takeaways from the J.P. Morgan Healthcare Conference 2024. From AI's potential in drug-making to the weight loss pills market and tax-exempt hospitals, read the insights here: https://t.co/40ZWlEqqpl @KFFHealthNews"#health, #healthpolicy, #healthreform
— David Moniz (@DavidMoniz15) January 22, 2024
Ambitions for Oneself and Achieving Objectives
Regarding JAMA and the JAMA Network, Dr. Bibbins-Domingo discussed her own goals. Following a year and a half as Editor-in-Chief, she demonstrated a willingness to carry out big plans, motivated by a thorough comprehension of the group and the dynamics at work.
Forward-Looking: A Year of Implementation
JAMA wants to be a reliable source while adjusting to the changing nature of science communication as 2024 approaches. Dr. Bibbins-Domingo sees a year of implementation to achieve her lofty objectives.
Accepting Science’s Excitement
To sum up, the AMA Update featuring Dr. Bibbins-Domingo offers an insight into the ever-changing field of medical journalism. Innovation, communication, and the ongoing quest of excellence in presenting science to a passionate and always changing audience are all anticipated in 2024. For all parties concerned, JAMA’s journey through the nexus of AI, medicines, and communication promises to be lucrative and challenging at the same time.
